A376930 Stock Overview
Engages in the in vitro diagnosis and remote diagnosis business worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Noul Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩2,210.00 |
52 Week High | ₩8,520.00 |
52 Week Low | ₩2,040.00 |
Beta | -0.32 |
11 Month Change | -14.01% |
3 Month Change | -7.53% |
1 Year Change | -11.16% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -52.01% |
Recent News & Updates
Recent updates
Shareholder Returns
A376930 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | -4.3% | -3.2% | -1.4% |
1Y | -11.2% | 14.0% | 0.1% |
Return vs Industry: A376930 underperformed the KR Medical Equipment industry which returned 14% over the past year.
Return vs Market: A376930 underperformed the KR Market which returned 0.1% over the past year.
Price Volatility
A376930 volatility | |
---|---|
A376930 Average Weekly Movement | 9.1% |
Medical Equipment Industry Average Movement | 5.9% |
Market Average Movement | 5.0% |
10% most volatile stocks in KR Market | 11.1% |
10% least volatile stocks in KR Market | 2.2% |
Stable Share Price: A376930's share price has been volatile over the past 3 months.
Volatility Over Time: A376930's weekly volatility has decreased from 14% to 9% over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | 117 | David Lim | www.noul.kr |
Noul Co.,Ltd. engages in the in vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis.
Noul Co.,Ltd. Fundamentals Summary
A376930 fundamental statistics | |
---|---|
Market cap | ₩81.65b |
Earnings (TTM) | -₩16.54b |
Revenue (TTM) | ₩2.26b |
36.1x
P/S Ratio-4.9x
P/E RatioIs A376930 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A376930 income statement (TTM) | |
---|---|
Revenue | ₩2.26b |
Cost of Revenue | ₩2.23b |
Gross Profit | ₩30.40m |
Other Expenses | ₩16.57b |
Earnings | -₩16.54b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -447.74 |
Gross Margin | 1.34% |
Net Profit Margin | -731.16% |
Debt/Equity Ratio | 3.1% |
How did A376930 perform over the long term?
See historical performance and comparison